"Louis Morgan Drugs #1 opened in 1952 focused on patient care. Today we serve a large community in and around Longview. We are dedicated to providing our customers with services that are customized to meet their needs. Whether it's prescription medications or over the counter products, we are here to answer any and all of your questions. If you haven't taken advantage of one of our many services, call or stop by and see us today!"

During the past decade, Louis Morgan Drug #1 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louis Morgan Drug #1" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "McNeil AB" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Louis Morgan Drug #1" are "Frequent Heartburn" (1 trials) and "Tobacco Dependence" (1 trials). Many other conditions were trialed in "Louis Morgan Drug #1" in a lesser frequency.

Most popular intervention types in "Louis Morgan Drug #1" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nicotine" (1 trials), "Placebo" (1 trials) and "Rabeprazole sodium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louis Morgan Drug #1" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Louis Morgan Drug #1". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Louis Morgan Drug #1, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Louis Morgan Drug #1, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".